The Tick-Borne Disease Panel 1 from IGeneX is a comprehensive laboratory test designed to detect antibodies and/or genetic material associated with common tick-borne pathogens, including Borrelia burgdorferi (Lyme disease), Babesia, and Anaplasma species. IGeneX specializes in tick-borne illness testing and uses proprietary methodologies developed to support broader detection sensitivity compared to standard reference lab panels. This panel is intended for individuals who have had potential tick exposure and are seeking detailed screening information to share with their healthcare provider.
Why It's Worth Considering: IGeneX has a long-standing focus specifically on tick-borne pathogens and employs multiple testing methodologies—including immunofluorescence assays and PCR—to support more thorough detection across common co-infections.
This product is in the Apotheca marketplace and has been assigned a Gabriel Score of pending evaluation. Detailed reviews from Amazon, iHerb, Reddit, practitioner citations, and clinical research will appear here as they're aggregated.
Apotheca is analyzing ingredient interactions, stacking compatibility, and timing recommendations for Tick-Borne Disease Panel 1. This data will be available soon.
